Carolyn Wang (@cbwang) header
Carolyn Wang (@cbwang) profile picture

Carolyn Wang

@cbwang

SVP Global Corp Comm at Ultragenyx, @JohnRitterFdn board member - also mother, beekeeper. I love science, curiosity and agents of change.

 SF
Ultragenyx.com
Joined November 2008
  • Tweets596
  • Following469
  • Followers693
76Media
Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)Photo by Carolyn Wang (@cbwang)
#VirBiotechnology News: We announced positive updated Phase 1 data results for our PSMA-targeting, dual-masked #TCE VIR-5500 in participants with metastatic castration-resistant prostate cancer #mCRPC. Learn more in the replay of our conference call ➡️ bit.ly/4tefwtZ
1
1
5
442
#VirBiotechnology News: We are proud to announce a global strategic collaboration with Astellas Pharma to advance our PSMA-targeting dual-masked T-cell engager #TCE VIR-5500 for the treatment of prostate cancer.➡️ bit.ly/4sbdI3K
1
1
2
417
Carolyn Wang retweeted
Alex Thompson (@AlexThomp) profile picture
Alex Thompson
@AlexThomp1 Oct 2025
Bernie Sanders and AOC do a joint video explaining their view of the shutdown.
738
2,473
394
14,456
3,950,703
We have people in power making broad claims around certain drugs and autism that have been continuously disproven. The degree to which those comments can undermine public health, do harm to women who are pregnant, create anxiety for parents who do have children who are autistic – is violence against the truth.
27,538
33,310
2,964
208,016
18,101,176
Ultragenyx $RARE gene therapy for rare liver ailment succeeds in late-stage trial statnews.com/2024/05/30/ultr… via @Jasonmmast

Ultragenyx gene therapy for rare liver ailment succeeds in late-stage trial

Ultragenyx said its gene therapy for a rare liver ailment, glycogen disease type 1A, succeeded in a Phase 3 trial, setting up a potential approval.

statnews.com
1
5
2
29
13,147
Come and knock on our door, Joyce DeWitt and Priscilla Barnes! It was a Three's Company reunion at our Evening from the Heart event and @gma captured it: abcnews.go.com/GMA/Culture/t… #AortaEd #AortaSupporta #AorticDissection
'Three's Company' stars have mini reunion at benefit for John Ritter: See the photos

'Three's Company' stars have mini reunion at benefit for John Ritter: See the photos

"Three's Company" stars Joyce DeWitt and Priscilla Barnes reunited this week at a benefit for late co-star John Ritter.

abcnews.com
2
8
870
Thank you to Kaley Cuoco and the rest of the 8 Simple Rules family for supporting our Evening from the Heart last week! Kaley discusses one of her favorite memories of John with @people: people.com/kaley-cuoco-honor… #AortaEd #AortaSupporta #AorticDissection
Kaley Cuoco Honors Late '8 Simple Rules' Costar John Ritter at the Heart Gala (Exclusive)

Kaley Cuoco Honors Late '8 Simple Rules' Costar John Ritter at the Heart Gala (Exclusive)

Kaley Cuoco attended The John Ritter Foundation for Aortic Health Gala on Thursday, May 9 at the Sunset Room Hollywood in Los Angeles, California to support her late costar. The two appeared on '8...

people.com
8
71
1,894
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx19 Apr 2024
At #WorldOrphanUSA, our CEO, Dr. Emil Kakkis, will take the stage to deliver a keynote presentation on using biomarkers for #RareDiseases. Nicole Miller, VP of Molecular Diagnostics, will also take part in a panel on #NewbornScreening and the future for rare disease. More below.
1
5
1,111
Carolyn Wang retweeted
BiotechTV (@BiotechTV) profile picture
BiotechTV
@BiotechTV16 Apr 2024
Company News: @ultragenyx's Emil Kakkis on this week's Angelman syndrome data, rare disease treatment modalities, and more. Full video: biotechtv.com/post/ultrageny…
1
5
4
32
9,637
Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition statnews.com/2024/04/15/ultr… via @ADeAngelis_bio for @statnews
Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome.

statnews.com
1
8
525
"There are so many rare diseases that have no treatments at all," says @ultragenyx CEO Dr. Emil Kakkis, who says his company has been working to improve the process for the latest precision gene therapies, and is hopeful the FDA may use accelerated approvals for treatment.
4
3
12
19,586
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx2 Nov 2023
Today at the North America Rare Disease Summit 2023 (#NARDS), Ultragenyx team member Lisa Kahlman, executive director, public policy & public affairs, interviewed Dr. Peter Marks on his view of leveraging the Accelerated Approval pathway in #RareDisease.
Image from Ultragenyx (@ultragenyx)
2
6
1,024
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx14 Oct 2023
Ultragenyx announces new data from the investigative Phase 2/3 Orbit study of setrusumab (UX143) in #OsteogenesisImperfecta (OI) at #ASBMR23. Learn more: ultragenyx.co/3txZhxA
Image from Ultragenyx (@ultragenyx)
4
1
17
1,472
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx13 Oct 2023
Join us virtually on Monday, October 16 at 8:30 AM ET to hear from two researchers leading our #OsteogenesisImperfecta program during #AnalystDay. Watch the live webcast here: bit.ly/3tlGOnL
Image from Ultragenyx (@ultragenyx)
1
1
508
For 20 years The JRF has worked to spread awareness of aortic health. Watch our video to learn more about the latest research developments and how you can help spread awareness of aortic dissection and save lives. youtu.be/oKxAExRX_us
20 Years of JRF - The Ritter Effect

20 Years of JRF - The Ritter Effect

For twenty years The John Ritter Foundation has worked to spread aw...

youtube.com
12
1
27
2,212
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx21 Jun 2023
Today, we celebrate the opening of our #GeneTherapy manufacturing facility in Bedford, MA, which will enable us to bring cutting-edge gene therapies to transform the lives of people living with #RareDiseases. Learn more: ultragenyx.co/3PG13Wz
Image from Ultragenyx (@ultragenyx)
2
1
11
713
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx5 Jun 2023
In partnership with @MereoBiopharma, we’re pleased to share data from the dose-selection Phase 2 portion of our pivotal Orbit study for patients living with #OsteogenesisImperfecta (OI). Read the press release for more details: bit.ly/3CbO7PZ
Image from Ultragenyx (@ultragenyx)
1
5
6
768
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx30 May 2023
The Orphan Drug Act was an important contribution for people living with #RareDiseases, but today many people living with ultrarare diseases are being left behind. Our CEO, Dr. Emil Kakkis, shares why it's time for an #ODA 2.0 to help support the ultrarare disease community.
7
1
27
4,825
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx10 May 2023
Thank you @FiercePharma for recognizing what we see every day — Emil’s "fierce" focus on bringing new medicines to people with #RareDiseases. Read more about why he is one of the Most Influential People in Biopharma: bit.ly/3BcOAB5
Image from Ultragenyx (@ultragenyx)
1
1
11
705
Carolyn Wang retweeted
Ultragenyx (@ultragenyx) profile picture
Ultragenyx@ultragenyx11 Apr 2023
People with #RareDiseases and their families are warriors – warriors who must overcome obstacles every day. To help prepare for the battle, each year members of the #RareDisease community attend the Rare Bootcamp. Learn more: ultragenyx.co/3Jq2Euv
5
1
9
1,477
Load more